Navigation Links
Schizophrenic patients may be given seroquel

Treating aggression in schizophrenic patients with the help of seroquel is effective//, says a new study.

Schizophrenia is a chronic severe disabling mental illness. Some of the symptoms suffered by schizophrenia are hallucinations seen or heard, feelings of being persecuted, becoming withdrawn, and deranged behavior. Schizophrenia can be treated symptomatically, but only one in five patients have a chance of full recovery. Although most schizophrenic patients are not aggressive, the disease is often stigmatized as that renders the patients violent. Only a small percentage of patients of this disease are hostile or violent.

Seroquel is a drug for antipsychotic treatment that can change the functions of the chemicals in the brain. The drug is generally used to treat patients with psychotic disabilities.

The new study done by researchers of Hospital General Universitario Gregorio Maranon, Spain, treatment with atypical antipsychotic seroquel (quetiapine) achieved significant benefit for aggressive episodes in schizophrenic patients. In aggressive behavior patterns of schizophrenia, the researchers reported that the effectiveness of seroquel more significant than the use of placebo. The patients not only found the medication effective, it was also well received by the body and tolerated without much side effects.

Reference: Human Psychopharmacology: Clinical and Experimental, June 2005
'"/>




Page: 1

Related medicine news :

1. Schizophrenics On Medication At An Increased Risk For Developing Diabetes
2. Schizophrenic Symptoms Need Combination Therapy
3. Music therapy for Schizophrenics
4. Schizophrenics At Greater Risk Of Developing Chronic Diseases
5. Sway Schizophrenics With Incentives to Avail Regular Treatment
6. HIV infected patients can travel safely abroad
7. New vaccine helps allergy and asthma patients
8. Doctors operate upon patients in candlelight- latest from the quake scene
9. New vaccine helps allergy and asthma patients
10. Are cancer patients being taken for a ride?
11. Alternative medicine more popular among HIV positive patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: